China Medical System Analysis

China Pink Sheet Analysis Notes

About 50.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.71. Some equities with similar Price to Book (P/B) outperform the market in the long run. China Medical System last dividend was issued on the 6th of September 2022. China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. China Medical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 5454 people.The quote for China Medical System is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on China Medical System please contact Kong Lam at 852 2369 7678 or go to https://www.cms.net.cn.

China Medical System Investment Alerts

China Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate China Medical's market, we take the total number of its shares issued and multiply it by China Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

China Profitablity

The company has Profit Margin (PM) of 0.36 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.37 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.37.

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how China Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling China shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as China Medical. By using and applying China Pink Sheet analysis, traders can create a robust methodology for identifying China entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

If you are still planning to invest in China Medical System check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Medical's history and understand the potential risks before investing.